Media
For media enquiries please contact:
media@evivebiotech.com
Latest Press Release
The First Patient was Dosed in Phase 2 Clinical Trial of F-652 in Patients with ACLF
- 3 December 2021
PLOS ONE Article Details IL-22’s Critical Role in Mitigating ARDS
- 12 November 2021
Evive Biotech Announces the Grand Opening of EWING R&D Center in San Francisco Bay Area
- 3 November 2021
Evive Biotech Announces the Appointment of Mr. Denny Hou as VP, Global Medical Research
- 28 October 2021
Evive Biotech Announces the Appointment of Dr. Kaiming Sun as VP, Clinical Biomarker
- 26 October 2021
Evive Biotech Announces the Appointment of Dr. Simon Li as Executive VP, Chief Medical Officer
- 15 October 2021
Evive Biotech Announces the Appointment of Dr. Jing Wang as VP, Clinical Pharmacology
- 12 October 2021
Evive Biotech’s Ryzneuta™ Marketing Authorization Application Accepted for Review by European Medicines Agency
- 8 October 2021
Evive Biotech Announces Recent Appointments: VP of Biometrics and VP of Clinical Operations
- 9 September 2021
